A Randomized Controlled Trial to Assess the Effectiveness of Hijamah bila Shart with Roghan e Baboona in Non specific low back pain and its potential role in improving the Quality of Life in Majeedia Unani Hospital South East Delhi
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Visual Analogue Scale
研究概览
简要总结
This study is Hospital based, Randomized Controlled Trial and conducted on Patients of Non-specific low back pain from OPDs of Majeedia Unani Hospital. The patients are randomly allocated to Experimental and Control group by using alternate method. Group A (Experimental group) will receive Hijama-bila-Shart (Muzliqa/ Gliding Cupping) therapy with Roghan-e-Baboona for 15 minutes on alternate days for two weeks and Group B (Control group) will receive Standard treatment for low back pain from Ilaj-bil-Tadbeer OPD of Majeedia Unani Hospital and Patients are assessed at baseline, at Day 14 (After the completion of Therapy) and at Day 21 (After one week of treatment free period. The findings will be recorded in Case Report form designed for the study
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of low back pain 2.Oswestry low back pain score up to 24 (mild to moderate disability) 3.willing to take Hijama therapy with Roghan-e-Baboona in experimental group
- •Willing to give written informed consent.
排除标准
- •Any previous spine surgery
- •Acute injury of Lumbosacral region
- •Patients with any specific causes of low back pain e.g., Vertebral fracture, herniated disc in the lumbar region, Spinal infections and spinal tumor
- •Major medical illness under treatment
- •Radiological investigation suggestive of any lower back pathology 6.Pregnant women
- •Patients not in a condition to give valid consent 9.
结局指标
主要结局
Visual Analogue Scale
时间窗: At baseline at 14 Day (After completion of therapy) and at 21 Day (After one week of treatment free period)
Oswestry Low back Disability Questionnaire
时间窗: At baseline at 14 Day (After completion of therapy) and at 21 Day (After one week of treatment free period)
次要结局
- SF12V2 Quality of Life Questionnaire(At baseline, after completion of therapy at 14 Day and after one week of treatment free period at day 21)
研究者
Shazia Khan
Jamia Hamdard